I think the most likely outcome of the Impress trial is that both the control and treatment arm are living longer than anticipated . The question is whether or not there is seperation between the groups and how much . The overall survival average has gotten so far beyond expectations that I anticipate that the groups have separated.
Not just football. The Biotech/Pharma season also begins after Labor Day . Medical Conferences / new data. Broker conferences institutional exposure . The season will end the first weekend in June ASCO which is the SuperBowl for oncology . Have a nice weekend before the opening kickoff!